These approaches are not mutually exclusive
This highlights the potential to exploit HO-1 as a valuable target for therapeutic intervention in DFU cases (Fig
Each peptide targets specific systems, allowing us to create personalized treatment plans based on your individual needs

Our work with Epic is creating a force multiplying effect, where health organizations using Epics EHR have immediate access to our bundled offerings, resulting in accelerated deployment, reduced operational burden, and most importantly its helping clinicians care for their patients by providing: - Patient education materials to support a deeper understanding of diagnosis, treatment plans, and next steps - Real-time access to medication and drug dosing information so clinicians can develop personalized treatment plans for their patients - An enterprise-grade platform to monitor and track drug data across the entire healthcare organizations workflow systems Together with other Wolters Kluwer Health solutions like UpToDate, Lippincott, and Ovid, we're equipping rural hospitals and clinicians with the tools they need to deliver equitable, quality care, no matter where they are
Saudi Med
10.1016/j.bbamem.2015.12.026 Biochim